KIRYAT ONO, Israel & NEW YORK--(BUSINESS WIRE)--GammaCan International, Inc. (OTC BB: GCAN), a developer of immunotherapies to treat melanoma and other cancers, today announced that Patrick Schnegelsberg, Chief Executive Officer, will provide a company overview and highlight GammaCan’s recent developments at the Rodman & Renshaw 8th Annual Healthcare Conference, at 11:00 AM EST on November 8th at the New York Palace Hotel in New York City.
